特斯拉
TSLA
英偉達
NVDA
Palantir
PLTR
4
蘋果
AAPL
5
Strategy
MSTR
美股市場個股詳情
ASND Ascendis Pharma A/S
- 138.180
- -7.560-5.19%
收盤價 03/10 16:00 (美東)
- 138.180
- 0.0000.00%
盤前 05:45 (美東)
82.69億總市值-19.53市盈率TTM
144.115最高價137.020最低價45.84萬股成交量143.700今開145.740昨收6364.06萬成交額0.77%換手率虧損市盈率(靜)5984.36萬總股本158.00052周最高-72.19市淨率82.04億流通值111.09052周最低--股息TTM5937.26萬流通股183.980歷史最高--股息率TTM4.87%振幅11.920歷史最低138.823平均價1股每手
關於Ascendis Pharma A/S公司
Ascendis Pharma AS是一家生物製藥公司，應用其TransCon技術平臺爲患者帶來有意義的改變。該公司的產品線包括內分泌學和腫瘤學，其中包括TransCon PTH， TransCon CNP等。該公司在北美、歐洲和世界其他地區開展業務，其大部分收入來自北美。
公司介紹
公司代碼ASND
公司名稱Ascendis Pharma A/S
上市日期2015/01/28
發行價格18.00
成立日期2006
CEOMr. Jan Moller Mikkelsen
所屬市場納斯達克
員工數量1017
證券類型存託憑證
ADS轉換比例1.0 : 1.0
年結日12-31
公司地址Tuborg Boulevard 12
城市Hellerup
省份首都地區
國家丹麥
郵編2900
電話45-70-22-22-44
董事高管
- 姓名
- 職務
- 年薪
- Jan Moller Mikkelsen
- President, Chief Executive Officer and Director
- --
- Scott T Smith
- Executive Vice President and Chief Financial Officer
- --
- Lotte Sonderbjerg
- Executive Vice President and Chief Administrative Officer
- --
- Michael Wolff Jensen
- Executive Vice President and Chief Legal Officer
- --
- Aimee Shu
- Executive Vice President and Chief Medical Officer
- --
- Mads Bodenhoff
- Senior Vice President, Head of Finance and Principal Accounting Officer
- --
- Dr. Stina Singel, M.D.
- Executive Vice President and Head of Clinical Development, Oncology
- --
- Flemming Steen Jensen
- Executive Vice President, Product Supply and Quality
- --
- Jay Donovan Wu
- Executive Vice President and U.S. President
- --
- Dr. Kennett Sprogoe, PhD
- Executive Vice President and Head of Innovation and Research
- --
- Dr. Albert Cha, M.D.,PhD
- Chairman of the Board
- --
- Siham Imani
- Independent Director
- --
- Lars Holtug
- Independent Director
- --
- Lisa Bright
- Independent Director
- --
- William Carl Fairey, Jr
- Independent Director
- --